Clinical Trials Logo

Clinical Trial Summary

This study will estimate the incidence of invasive pneumococcal disease in members of the Northern Kaiser Permanente healthcare system during each of the 5 following introduction of Prevnar 13.


Clinical Trial Description

No sampling as no subjects are enrolled ;


Study Design


Related Conditions & MeSH terms


NCT number NCT01128439
Study type Observational
Source Pfizer
Contact
Status Completed
Phase
Start date July 2010
Completion date April 2015

See also
  Status Clinical Trial Phase
Completed NCT00853749 - Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine Phase 3
Completed NCT00227188 - Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain. N/A
Recruiting NCT00885625 - 7-valent Pneumococcal Conjugated Vaccination Phase 4
Completed NCT04464291 - An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years N/A
Completed NCT01083459 - Impact of PCV on Disease and Colonization Among Native American Communities N/A
Completed NCT00371878 - Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection Phase 4